Huber Capital Management’s Utah Medical Products UTMD Stock Holding History

Huber Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Sell	29,009 -6,906	-19%	-$459K	0.29%	55
2026 Q1	$2.23M	Sell	35,915 -925	-3%	-$58.3K	0.34%	51
2025 Q4	$2.06M	Sell	36,840 -11,012	-23%	-$638K	0.3%	51
2025 Q3	$3.01M	Sell	47,852 -7,496	-14%	-$443K	0.48%	44
2025 Q2	$3.15M	Buy	55,348 +15,529	+39%	+$845K	0.54%	44
2025 Q1	$2.23M	Buy	39,819 +11,149	+39%	+$668K	0.42%	49
2024 Q4	$1.76M	Buy	+28,670	New	+$1.85M	0.35%	57

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Huber Capital Management's UTMD Position: Q2 2026 in Review

Huber Capital Management reduced its Utah Medical Products (UTMD) stake by 19% in Q2 2026, selling an estimated $459K and leaving 29,009 shares worth $2M. The position accounts for 0.29% of the portfolio, ranked #55.

Huber Capital Management first reported a position in UTMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.15M in Q2 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

Huber Capital Management held 29,009 shares of Utah Medical Products worth $2M as of Q2 2026.
Huber Capital Management sold 6,906 Utah Medical Products shares in Q2 2026, an estimated $459K.
Utah Medical Products made up 0.29% of Huber Capital Management's portfolio in Q2 2026, its #55 holding.
Huber Capital Management first reported a position in Utah Medical Products in Q4 2024 and has held it in 7 quarters since.
Huber Capital Management's Utah Medical Products position peaked at $3.15M in Q2 2025.
114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Huber Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.